Particulate Matter in Injectable Drugs: Evaluation of Risks to Patients
Pharmaceutical Technology in Hospital Pharmacy · 2016
DOI: 10.1515/pthp-2016-0004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Technology in Hospital Pharmacy, 2016. Verfasst von Maxime Perez und 4 weiteren Autor:innen. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 218 Literaturangaben.
Abstract (Originalsprache)
One of the fundamental principles guiding the pharmaceutical quality of parenteral products is to prevent injecting contaminants from microbiological, chemical or physical sources. It is just as difficult to ensure the absence of chemical and particulate contaminants in injectable products as it is to weigh up the microbiological risk. The problem of particulate matter is mainly related to the preparing and administrating of injectable drugs rather than through the contamination of marketed products. Particulate contamination also arises
Zitieren
APA
Perez, M., Maiguy-Foinard, A., Barthélémy, C., Décaudin, B., & Odou, P. (2016). Particulate Matter in Injectable Drugs: Evaluation of Risks to Patients. Pharmaceutical Technology in Hospital Pharmacy. https://doi.org/10.1515/pthp-2016-0004
Vancouver
Perez M, Maiguy-Foinard A, Barthélémy C, Décaudin B, Odou P. Particulate Matter in Injectable Drugs: Evaluation of Risks to Patients. Pharmaceutical Technology in Hospital Pharmacy. 2016. doi:10.1515/pthp-2016-0004
BibTeX
@article{Perez2016,
author = {Perez, Maxime and Maiguy-Foinard, Aurélie and Barthélémy, Christine and Décaudin, Bertrand and Odou, Pascal},
title = {Particulate Matter in Injectable Drugs: Evaluation of Risks to Patients},
journal = {Pharmaceutical Technology in Hospital Pharmacy},
year = {2016},
doi = {10.1515/pthp-2016-0004}
}
EUVIMED